OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain
OKYO Pharma Ltd (NASDAQ:OKYO) announced that it has received positive feedback from a US Food and Drug Administration Type D ...
stc pay cardholders can complete e-commerce payments using device-based biometric authentication and passkeys.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results